|
1
|
Huber LC, Distler O, Tarner I, Gay RE, Gay
S and Pap T: Synovial fibroblasts: Key players in rheumatoid
arthritis. Rheumatology (Oxford). 45:669–675. 2006. View Article : Google Scholar
|
|
2
|
Noss EH and Brenner MB: The role and
therapeutic implications of fibroblast-like synoviocytes in
inflammation and cartilage erosion in rheumatoid arthritis. Immunol
Rev. 223:252–270. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lafyatis R, Thompson NL, Remmers EF,
Flanders KC, Roche NS, Kim SJ, Case JP, Sporn MB, Roberts AB and
Wilder RL: Transforming growth factor-beta production by synovial
tissues from rheumatoid patients and streptococcal cell wall
arthritic rats. Studies on secretion by synovial fibroblast-like
cells and immuno-histologic localization. J Immunol. 143:1142–1148.
1989.PubMed/NCBI
|
|
4
|
Chu CQ, Field M, Feldmann M and Maini RN:
Localization of tumor necrosis factor alpha in synovial tissues and
at the cartilage-pannus junction in patients with rheumatoid
arthritis. Arthritis Rheum. 34:1125–1132. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chu CQ, Field M, Allard S, Abney E,
Feldmann M and Maini RN: Detection of cytokines at the
cartilage/pannus junction in patients with rheumatoid arthritis:
Implications for the role of cytokines in cartilage destruction and
repair. Br J Rheumatol. 31:653–661. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang HG, Wang Y, Xie JF, Liang X, Liu D,
Yang P, Hsu HC, Ray RB and Mountz JD: Regulation of tumor necrosis
factor alpha-mediated apoptosis of rheumatoid arthritis synovial
fibroblasts by the protein kinase Akt. Arthritis Rheum.
44:1555–1567. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alonso-Ruiz A, Pijoan JI, Ansuategui E,
Urkaregi A, Calabozo M and Quintana A: Tumor necrosis factor alpha
drugs in rheumatoid arthritis: Systematic review and meta-analysis
of efficacy and safety. BMC Musculoskelet Disord. 9:522008.
View Article : Google Scholar
|
|
8
|
Li G, Zhang Y, Qian Y, Zhang H, Guo S,
Sunagawa M, Hisamitsu T and Liu Y: Interleukin-17A promotes
rheumatoid arthritis synoviocytes migration and invasion under
hypoxia by increasing MMP2 and MMP9 expression through NF-κB/HIF-1α
pathway. Mol Immunol. 53:227–236. 2013. View Article : Google Scholar
|
|
9
|
Criswell LA: Gene discovery in rheumatoid
arthritis highlights the CD40/NF-kappaB signaling pathway in
disease pathogenesis. Immunol Rev. 233:55–61. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Foxwell B, Browne K, Bondeson J, Clarke C,
de Martin R, Brennan F and Feldmann M: Efficient adenoviral
infection with IkappaB alpha reveals that macrophage tumor necrosis
factor alpha production in rheumatoid arthritis is NF-kappaB
dependent. Proc Natl Acad Sci USA. 95:8211–8215. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hwang SY, Kim JY, Kim KW, Park MK, Moon Y,
Kim WU and Kim HY: IL-17 induces production of IL-6 and IL-8 in
rheumatoid arthritis synovial fibroblasts via NF-kappaB- and
PI3-kinase/Akt-dependent pathways. Arthritis Res Ther. 6:R120–R128.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kagoya Y, Yoshimi A, Kataoka K, Nakagawa
M, Kumano K, Arai S, Kobayashi H, Saito T, Iwakura Y and Kurokawa
M: Positive feedback between NF-κB and TNF-α promotes
leukemia-initiating cell capacity. J Clin Invest. 124:528–542.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wendling D and Toussirot E:
TNF-alpha-targeted therapy in rheumatoid arthritis. Rev Rhum Engl
Ed. 66:187–191. 1999.PubMed/NCBI
|
|
14
|
Ding R, Li P, Song D, Zhang X and Bi L:
Predictors of response to TNF-α antagonist therapy in Chinese
rheumatoid arthritis. Clin Rheumatol. 34:1203–1210. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cavazzana I, Taraborelli M, Fredi M,
Tincani A and Franceschini F: Aseptic meningitis occurring during
anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing
spondylitis. Clin Exp Rheumatol. 32:732–734. 2014.PubMed/NCBI
|
|
16
|
Sakthiswary R and Das S: The effects of
TNF α antagonist therapy on bone metabolism in rheumatoid
arthritis: A systematic review. Curr Drug Targets. 14:1552–1557.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oudemans-van Straaten HM, Kellum JA and
Bellomo R: Clinical review: Anticoagulation for continuous renal
replacement therapy-heparin or citrate? Crit Care. 15:2022011.
View Article : Google Scholar
|
|
18
|
Ramacciotti E, Clark M, Sadeghi N,
Hoppensteadt D, Thethi I, Gomes M and Fareed J: Review:
Contaminants in heparin: Review of the literature, molecular
profiling, and clinical implications. Clin Appl Thromb Hemost.
17:126–135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Zheng Z, Li X and Ma X:
Unfractionated heparin inhibits lipopolysaccharide-induced
inflammatory response through blocking p38 MAPK and NF-κB
activation on endothelial cell. Cytokine. 60:114–121. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee JH, Lee J, Seo GH, Kim CH and Ahn YS:
Heparin inhibits NF-kappaB activation and increases cell death in
cerebral endothelial cells after oxygen-glucose deprivation. J Mol
Neurosci. 32:145–154. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Crisostomo PR, Wang Y, Markel TA, Wang M,
Lahm T and Meldrum DR: Human mesenchymal stem cells stimulated by
TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B
- but not JNK-dependent mechanism. Am J Physiol Cell Physiol.
294:675–682. 2008. View Article : Google Scholar
|
|
23
|
Zheng Y, Ouaaz F, Bruzzo P, Singh V,
Gerondakis S and Beg AA: NF-kappa B RelA (p65) is essential for
TNF-alpha-induced fas expression but dispensable for both
TCR-induced expression and activation-induced cell death. J
Immunol. 166:4949–4957. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schütze S, Wiegmann K, Machleidt T and
Krönke M: TNF-induced activation of NF-kappa B. Immunobiology.
193:193–203. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McDonald PP, Bald A and Cassatella MA:
Activation of the NF-kappaB pathway by inflammatory stimuli in
human neutrophils. Blood. 89:3421–3433. 1997.PubMed/NCBI
|
|
26
|
Youn J, Kim HY, Park JH, Hwang SH, Lee SY,
Cho CS and Lee SK: Regulation of TNF-alpha-mediated hyperplasia
through TNF receptors, TRAFs, and NF-kappaB in synoviocytes
obtained from patients with rheumatoid arthritis. Immunol Lett.
83:85–93. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Emery P: Rheumatoid arthritis:
International disparities in access to anti-TNF therapy. Nat Rev
Rheumatol. 7:197–198. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ribic C, Lim W, Cook D and Crowther M:
Low-molecular-weight heparin thromboprophylaxis in medical-surgical
critically ill patients: A systematic review. J Crit Care.
24:197–205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cao G, Wu JX and Wu QH: Low molecular
weight heparin suppresses lymphatic endothelial cell proliferation
induced by vascular endothelial growth factor C in vitro. Chin Med
J (Engl). 122:1570–1574. 2009.
|
|
30
|
Khorana AA, Sahni A, Altland OD and
Francis CW: Heparin inhibition of endothelial cell proliferation
and organization is dependent on molecular weight. Arterioscler
Thromb Vasc Biol. 23:2110–2115. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cariou R, Harousseau JL and Tobelem G:
Inhibition of human endothelial cell proliferation by heparin and
steroids. Cell Biol Int Rep. 12:1037–1047. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guttridge DC, Albanese C, Reuther JY,
Pestell RG and Baldwin AS Jr: NF-kappaB controls cell growth and
differentiation through transcriptional regulation of cyclin D1.
Mol Cell Biol. 19:5785–5799. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ettelaie C, Fountain D, Collier ME, Elkeeb
AM, Xiao YP and Maraveyas A: Low molecular weight heparin
downregulates tissue factor expression and activity by modulating
growth factor receptor-mediated induction of nuclear factor-κB.
Biochim Biophys Acta. 1812:1591–1600. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li X, Li X, Zheng Z, Liu Y and Ma X:
Unfractionated heparin suppresses lipopolysaccharide-induced
monocyte chemoattractant protein-1 expression in human
microvascular endothelial cells by blocking Krüppel-like factor 5
and nuclear factor-κB pathway. Immunobiology. 219:778–785. 2014.
View Article : Google Scholar : PubMed/NCBI
|
